Which has grown faster, MRNA or WST?

Over the past five years, WST grew revenue faster — MRNA at a -2.60% CAGR versus WST at 6.72%.

Does MRNA or WST pay a bigger dividend?

WST pays a dividend (0.25% yield) while MRNA does not currently pay one.

Is MRNA or WST more profitable?

WST runs the higher net margin — MRNA at -143.55% versus WST at 16.85%.

Which has been the better investment, MRNA or WST?

Over the past 5-year, WST delivered the higher annualized total return — MRNA at -21.05% versus WST at 17.45%. Past performance doesn't predict future results.

Moderna, Inc. (MRNA) vs West Pharmaceutical Services, Inc. (WST)

WST leads on 7 of 10 compared metrics.

A side-by-side comparison of Moderna, Inc. and West Pharmaceutical Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 26, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

West Pharmaceutical Services, Inc.

$24.79B

$350.85Healthcare

Total return — MRNA vs WST

growth of $100 · last 8y

MRNA +262.6%WST +230.9%MRNA compounded faster

MRNA WST

MRNA vs WST: by the numbers

•MRNA is the larger company ($26.35B vs $24.79B market cap).
•WST is profitable (16.85% net margin) while MRNA runs a net loss (-143.55%).
•WST grew revenue faster over the past five years (6.72% vs -2.60% CAGR).
•WST pays a dividend (0.25% yield) while MRNA does not currently pay one.

Which is better, MRNA or WST?

Metric tally: MRNA 3 · WST 7

It depends on what you're optimizing for:

GrowthWST(faster 5Y revenue CAGR)

QualityWST(higher ROIC)

Metrics side by side

Valuation

Metric	MRNA	WST
P/E ratio	—	46.84
Forward P/E	—	36.63
P/S ratio	10.61	7.89●
P/B ratio	3.19●	8.49
PEG ratio	—	33.99
EV / EBITDA	—	29.94
FCF yield	—	1.80%

Profitability

Metric	MRNA	WST
Gross margin	55.35%●	36.24%
Operating margin	-153.35%	20.67%●
Net margin	-143.55%	16.85%●
ROE	-43.12%	18.15%●
ROIC	-29.70%	13.62%●

Dividends

Metric	MRNA	WST
Dividend yield	—	0.25%
Payout ratio	—	12.88%

Growth (annualized)

Metric	MRNA	WST
Revenue CAGR (5Y)	-2.60%	6.72%●
EPS CAGR (5Y)	—	7.85%
FCF CAGR (5Y)	126.92%●	8.32%
Total return CAGR (5Y)	-21.05%	-0.26%●

Frequently asked

Which is better, MRNA or WST?: It depends on your goal. growth: WST (faster 5Y revenue CAGR); quality: WST (higher ROIC). Across all compared metrics, WST leads 7 to 3.
Which has grown faster, MRNA or WST?: Over the past five years, WST grew revenue faster — MRNA at a -2.60% CAGR versus WST at 6.72%.
Does MRNA or WST pay a bigger dividend?: WST pays a dividend (0.25% yield) while MRNA does not currently pay one.
Is MRNA or WST more profitable?: WST runs the higher net margin — MRNA at -143.55% versus WST at 16.85%.
Which has been the better investment, MRNA or WST?: Over the past 5-year, WST delivered the higher annualized total return — MRNA at -21.05% versus WST at 17.45%. Past performance doesn't predict future results.

Go deeper

Full MRNA analysis Full WST analysis Interactive comparison tool

Dig into the metrics

Moderna P/E ratio West Pharmaceutical Services P/E ratio Moderna dividend yield West Pharmaceutical Services dividend yield Moderna ROE West Pharmaceutical Services ROE Moderna operating margin West Pharmaceutical Services operating margin Moderna revenue growth West Pharmaceutical Services revenue growth Moderna free cash flow West Pharmaceutical Services free cash flow

Moderna & West Pharmaceutical Services appear in these rankings

Dividend Aristocrats Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 26, 2026.